← All organizations

Highest phase reached
Phase 3
First clinical trial
Jan 1, 1993Last known activity
Aug 5, 2025
Timeline
1960s
- Jan 1, 1965
Swiss Group for Clinical Cancer Research— Founded
Drugs by trial phase (99 distinct, 123 trials)
Phase 3 (49 own, 0 via acquisition)
Phase 2 (44 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Bile Duct Neoplasms
- Biliary Tract Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Cholangiocarcinoma
- Colonic Neoplasms
- Colorectal Neoplasms
- Esophageal Neoplasms
- Gallbladder Neoplasms
- Gastrointestinal Stromal Tumors
- Hand-Foot Syndrome
- Head and Neck Neoplasms
- Inflammatory Breast Neoplasms
- Leukemia
- Leukemia, Hairy Cell
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Melanoma
- Mesothelioma
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Nausea
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Plasmacytoma
- Polycythemia
- Polycythemia Vera
- Preleukemia
- Primary Myelofibrosis
- Prostatic Neoplasms
- Rectal Neoplasms
- Sarcoma
- Seminoma
- Small Cell Lung Carcinoma
- Stomach Neoplasms
- Syndrome
- Testicular Neoplasms
- Thrombocythemia, Essential
- Thrombocytosis
- Urinary Bladder Neoplasms
- Vomiting
Recent trials (50)
- NCT07075016CollaboratorPhase 3Aug 5, 2025
- NCT06452394Lead sponsorPhase 2Jan 1, 2025
- NCT06358573Lead sponsorPhase 2Oct 24, 2024
- NCT06401980Lead sponsorPhase 2Oct 22, 2024
- NCT06284122CollaboratorPhase 3Jun 7, 2024
- NCT05815927CollaboratorPhase 3Jan 1, 2024
- NCT04630730Lead sponsorPhase 2Dec 31, 2021
- NCT04629781Lead sponsorPhase 1May 28, 2021
- NCT04472949Lead sponsorPhase 2Jan 31, 2021
- NCT04480372Lead sponsorPhase 2Dec 31, 2020
- NCT04604067Lead sponsorPhase 2Dec 31, 2020
- NCT04608318CollaboratorPhase 3Dec 31, 2020
- NCT04245514Lead sponsorPhase 2Mar 31, 2020
- NCT04212026Lead sponsorPhase 2Mar 31, 2020
- NCT04097470CollaboratorPhase 2Sep 16, 2019
Details
- Founded
- Bern, CH Jan 1, 1965
- Last known activity
- Aug 5, 2025